Titlebook: Bone Marrow Biopsy Pathology; A Practical Guide Christine Beham-Schmid,Annette Schmitt-Graeff Book 2020 Springer-Verlag GmbH Germany, part

Madison

書(shū)目名稱(chēng)Bone Marrow Biopsy Pathology影響因子(影響力)




書(shū)目名稱(chēng)Bone Marrow Biopsy Pathology影響因子(影響力)學(xué)科排名




書(shū)目名稱(chēng)Bone Marrow Biopsy Pathology網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱(chēng)Bone Marrow Biopsy Pathology網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱(chēng)Bone Marrow Biopsy Pathology被引頻次




書(shū)目名稱(chēng)Bone Marrow Biopsy Pathology被引頻次學(xué)科排名




書(shū)目名稱(chēng)Bone Marrow Biopsy Pathology年度引用




書(shū)目名稱(chēng)Bone Marrow Biopsy Pathology年度引用學(xué)科排名




書(shū)目名稱(chēng)Bone Marrow Biopsy Pathology讀者反饋




書(shū)目名稱(chēng)Bone Marrow Biopsy Pathology讀者反饋學(xué)科排名

Morphine

占卜者

Bone Changes Found in Bone Marrow Biopsies, homeostasis of minerals, and it shelters the bone marrow which provides the blood elements. The metabolites of Vitamin D, parathyroid hormones, and calcitonin are among the most important regulators in the complex mechanism for the control of the calcium mechanism and the sound condition of bone. T

BUCK

Inflammatory and Infectious Diseases,thermore, bone marrow analysis has great importance in the evaluation of non-hematologic conditions. Various chemical toxins, including minerals, as well as radiation may severely affect the bone marrow cells and stroma. In patients with fever of unknown origin (FUO), among others in patients with .

MARS

Malignant Lymphomas,phomas (HL) and non-Hodgkin lymphomas (NHL) as well as classification of malignant lymphomas according to WHO is possible when immunohistochemistry is used. Ideally, additional flow cytometric immunophenotypic studies, FISH, and molecular investigations are performed to estimate lineage, maturation

武器

,Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of ,, or?with ,c disease groups involving rearrangement of platelet-derived growth factor receptor α (.), platelet-derived growth factor receptor β (.), fibroblast growth factor receptor 1 (.) or is associated with ., a provisional WHO entity [1–3] (Table 10.1). The presentation of the disorders is heterogeneous:

rheumatology

Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN),re listed in the MDS/MPN category: chronic myelomonocytic leukemia (CMML), atypical chronic myeloid leukemia (aCML), .-negative, juvenile myelomonocytic leukemia (JMML), myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T), and myelodysplastic/myelopr

煩憂

Acute Leukemia of Myeloid, Lymphoid, and Ambiguous Lineage and Related Malignancies,ting with high peripheral white blood cell counts and a reversed white and red blood cell balance [1]. The designation “acute leukemia” (AL) is actually applied to a heterogeneous group of immature clonal hematopoietic neoplasms occurring in all age groups. The large majority of AL is derived from e

詩(shī)集

免除責(zé)任